Status: Not yet recruiting
Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases
This study intends to conduct a prospective single-center open single-arm multi-dose escalation study on therapeutic immunological agent treatment in patients with Lymphoproliferative disease associated with EBV to observe the safety and efficacy.
Participants needed: 27
Trial details
Phase: Phase 1Age: 2-70Biological sex: AllType: InterventionalSponsor: West China HospitalUpdated: Oct 30, 2024Locations: 1
Eligibility criteria
Persistent or recurrent infectious IM-like symptoms lasting for more than 3 mont... [+2]
For CAEBV patients and others with EBV-LPD 1). Participated in other drug clinic... [+1]